Biosimilars

Your saved search

Your RSS Feed

. 2014 Jul;13(7):788-90.

Jerry Bagel. J Drugs Dermatol. 2014 Jul.

. 2014 Jul;13(7):788-90.

No abstract available

Similar articles

Tracking the price of existing biologics when drugs enter the market.
Stiff KM, Cline A, Feldman SR. Stiff KM, et al. Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):375-377. doi: 10.1080/14737167.2019.1630274. Epub 2019 Jun 12. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 31177860 No abstract available.
Are biosimilars patentable?
Rolfe D, Parker J, Morgan M. Rolfe D, et al. Expert Opin Ther Pat. 2016 Aug;26(8):871-5. doi: 10.1080/13543776.2016.1193156. Epub 2016 Jun 23. Expert Opin Ther Pat. 2016. PMID: 27215647
Forum discusses biosimilars, better biologicals.
Thompson CA. Thompson CA. Am J Health Syst Pharm. 2011 Dec 1;68(23):2210. doi: 10.2146/news110081. Am J Health Syst Pharm. 2011. PMID: 22095804 No abstract available.
A GUIDE TO FOLLOW-ON BIOLOGICS AND BIOSIMILARS WITH A FOCUS ON INSULIN.
Dolinar R, Lavernia F, Edelman S. Dolinar R, et al. Endocr Pract. 2018 Feb;24(2):195-204. doi: 10.4158/EP161728.RA. Endocr Pract. 2018. PMID: 29466056 Review.
Biosimilars: biologics that meet patients' needs and healthcare economics.
McCamish M, Yoon W, McKay J. McCamish M, et al. Am J Manag Care. 2016 Sep;22(13 Suppl):S439-S442. Am J Manag Care. 2016. PMID: 28719221 Review.

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks.
Gronde TV, Uyl-de Groot CA, Pieters T. Gronde TV, et al. PLoS One. 2017 Aug 16;12(8):e0182613. doi: 10.1371/journal.pone.0182613. eCollection 2017. PLoS One. 2017. PMID: 28813502 Free PMC article.